AU2008280437B2 - Pharmaceutical preparations comprising electrochemically activated hypochlorite solutions - Google Patents

Pharmaceutical preparations comprising electrochemically activated hypochlorite solutions Download PDF

Info

Publication number
AU2008280437B2
AU2008280437B2 AU2008280437A AU2008280437A AU2008280437B2 AU 2008280437 B2 AU2008280437 B2 AU 2008280437B2 AU 2008280437 A AU2008280437 A AU 2008280437A AU 2008280437 A AU2008280437 A AU 2008280437A AU 2008280437 B2 AU2008280437 B2 AU 2008280437B2
Authority
AU
Australia
Prior art keywords
preparation
electrochemically activated
salt solution
activated salt
content
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2008280437A
Other languages
English (en)
Other versions
AU2008280437A1 (en
Inventor
Mihran Baronian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Azad Pharma AG
Original Assignee
Azad Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Azad Pharma AG filed Critical Azad Pharma AG
Publication of AU2008280437A1 publication Critical patent/AU2008280437A1/en
Application granted granted Critical
Publication of AU2008280437B2 publication Critical patent/AU2008280437B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/10—Halogens or compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/10—Halogens or compounds thereof
    • A61L12/107—Hypohalites; Active halogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/0005—Other compounding ingredients characterised by their effect
    • C11D3/0078—Compositions for cleaning contact lenses, spectacles or lenses
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/395—Bleaching agents
    • C11D3/3956—Liquid compositions
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D2111/00—Cleaning compositions characterised by the objects to be cleaned; Cleaning compositions characterised by non-standard cleaning or washing processes
    • C11D2111/40—Specific cleaning or washing processes
    • C11D2111/46—Specific cleaning or washing processes applying energy, e.g. irradiation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Eyeglasses (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
AU2008280437A 2007-07-26 2008-07-28 Pharmaceutical preparations comprising electrochemically activated hypochlorite solutions Ceased AU2008280437B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US95203507P 2007-07-26 2007-07-26
US60/952,035 2007-07-26
US98818107P 2007-11-15 2007-11-15
US60/988,181 2007-11-15
PCT/EP2008/006193 WO2009013019A2 (en) 2007-07-26 2008-07-28 Pharmaceutical preparations comprising electrochemically activated hypochlorite solutions

Publications (2)

Publication Number Publication Date
AU2008280437A1 AU2008280437A1 (en) 2009-01-29
AU2008280437B2 true AU2008280437B2 (en) 2012-11-29

Family

ID=40239573

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2008280437A Ceased AU2008280437B2 (en) 2007-07-26 2008-07-28 Pharmaceutical preparations comprising electrochemically activated hypochlorite solutions

Country Status (10)

Country Link
US (1) US20100266710A1 (enExample)
EP (1) EP2178501B1 (enExample)
JP (1) JP5872159B2 (enExample)
KR (2) KR101633449B1 (enExample)
CN (2) CN101778621B (enExample)
AU (1) AU2008280437B2 (enExample)
CA (1) CA2694929C (enExample)
ES (1) ES2671372T3 (enExample)
RU (1) RU2554802C2 (enExample)
WO (1) WO2009013019A2 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2422792A1 (de) 2010-08-26 2012-02-29 Caliopa AG Elektrochemisch aktivierte Lösung auf Wasserbasis und Verwendung der Lösung
SI2374762T1 (sl) 2010-03-31 2013-05-31 Caliopa Ag Postroj in postopek za tvorjenje elektrokemično aktivirane raztopine
WO2011120701A1 (de) * 2010-03-31 2011-10-06 Aseca Ag Elektrochemisch aktivierte lösung auf wasserbasis und verwendung der lösung
EP2431056A1 (de) * 2010-09-16 2012-03-21 Caliopa AG Pharmazeutische Zusammensetzung, enthaltend elektrochemisch aktivierte Salzlösung
EP2543359A1 (de) * 2011-07-08 2013-01-09 Caliopa AG Gel zur Verwendung in einem Wundbehandlungsmittel
EP2567689A1 (en) * 2011-09-12 2013-03-13 Visiotact Pharma Ophthtalmic compositions comprising prostaglandin F2 alpha derivatives and hyaluronic acid
CA2848778C (en) * 2011-09-16 2017-04-25 Zurex Pharmagra, Llc Systems and methods for generating germicidal compositions
US10617716B2 (en) * 2014-12-16 2020-04-14 Urgo Us, Inc. Hypochlorous acid formulations and methods for treating skin conditions
WO2018074421A1 (ja) * 2016-10-21 2018-04-26 ライオン株式会社 眼科用剤及び眼科用薬
US20200397934A1 (en) 2017-11-27 2020-12-24 Sanixtreme Gmbh & Co. Kg Formulation for forming a disinfecting foam
EP3593862A1 (en) 2018-07-12 2020-01-15 Azad Pharma AG Electrochemically activated salt solution
EP3919047A1 (en) * 2020-06-03 2021-12-08 AZAD Pharma AG Microemulsion for the treatment of dry eye syndrome
WO2022081297A1 (en) * 2020-10-12 2022-04-21 The Regents Of The University Of Colorado, A Body Corporate Compositions and methods for lowering intracranial pressure by intranasal agent administration

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000024431A1 (en) * 1998-10-23 2000-05-04 Radical Waters Ip (Pty) Limited Method for applying bactericidal solutions

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2153553A1 (en) * 1994-07-13 1996-01-14 Hidekazu Suzuki Stable lipid emulsion
JPH10236961A (ja) * 1997-02-25 1998-09-08 Nobel Igaku Kenkyusho:Kk 電解酸性水を用いた眼科用剤
WO2000033757A1 (en) * 1998-12-09 2000-06-15 Advanced H¿2?O Inc. A system for decontamination of dental unit waterlines using electrolyzed water
RU2148027C1 (ru) * 1999-02-01 2000-04-27 Бахир Витольд Михайлович Способ получения дезинфицирующего раствора - нейтрального анолита анд
US7393522B2 (en) * 2000-01-12 2008-07-01 Novabay Pharmaceuticals, Inc. Physiologically balanced, ionized, acidic solution and methodology for use in wound healing
CN1406142A (zh) * 2000-02-04 2003-03-26 水基Ip股份有限公司 牙科设备和操作该设备的方法
RU2180605C1 (ru) * 2000-07-24 2002-03-20 Завод "Автоматика" Способ внутриушной ультразвуковой терапии хронических средних отитов
US20060264353A1 (en) * 2002-03-21 2006-11-23 Maxey Kirk M Prostaglandin f2alpha analogs and their use in combination with antimicrobial proteins for the treatment of glaucoma and intraocular hypertension
US20040191332A1 (en) * 2003-03-27 2004-09-30 Allergan, Inc. Preserved ophthalmic compositions
US20050196462A1 (en) * 2003-12-30 2005-09-08 Oculus Innovative Sciences, Inc. Topical formulation containing oxidative reductive potential water solution and method for using same
US20050139808A1 (en) * 2003-12-30 2005-06-30 Oculus Innovative Sciences, Inc. Oxidative reductive potential water solution and process for producing same
KR101319772B1 (ko) * 2004-11-09 2013-10-23 노바갈리 파르마 에스 에이 면역 억제제를 포함하는 안과용 유제
CA2602522C (en) * 2005-03-23 2014-09-09 Oculus Innovative Sciences, Inc. Method of treating skin ulcers using oxidative reductive potential water solution
JP5186217B2 (ja) * 2005-11-28 2013-04-17 千寿製薬株式会社 Ｐｐａｒアゴニスト含有医薬
KR101499824B1 (ko) * 2006-01-20 2015-03-06 오클루스 이노바티브 사이언시즈 인코포레이티드 산화 환원 전위 수용액을 사용한 염증 및 과민증의 치료 또는 예방 방법

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000024431A1 (en) * 1998-10-23 2000-05-04 Radical Waters Ip (Pty) Limited Method for applying bactericidal solutions

Also Published As

Publication number Publication date
KR101733723B1 (ko) 2017-05-10
WO2009013019A2 (en) 2009-01-29
JP2010534629A (ja) 2010-11-11
KR20150093244A (ko) 2015-08-17
AU2008280437A1 (en) 2009-01-29
CA2694929A1 (en) 2009-01-29
RU2554802C2 (ru) 2015-06-27
CA2694929C (en) 2016-10-18
JP5872159B2 (ja) 2016-03-01
CN105213299A (zh) 2016-01-06
WO2009013019A3 (en) 2009-04-09
CN101778621A (zh) 2010-07-14
CN101778621B (zh) 2015-09-09
KR101633449B1 (ko) 2016-06-24
ES2671372T3 (es) 2018-06-06
EP2178501B1 (en) 2018-05-02
EP2178501A2 (en) 2010-04-28
US20100266710A1 (en) 2010-10-21
KR20100051817A (ko) 2010-05-18
RU2010107043A (ru) 2011-09-10

Similar Documents

Publication Publication Date Title
AU2008280437B2 (en) Pharmaceutical preparations comprising electrochemically activated hypochlorite solutions
US20160143944A1 (en) Antimicrobial compositions comprising hypochlorous acid and silver
TW200942262A (en) Aqueous pharmaceutical compositions containing borate-polyol complexes
KR20100017168A (ko) Ｎ-할로겐화 아미노산 제제 및 세정 및 소독 방법
CN102858352B (zh) 含有鏻抗微生物剂的药物组合物
KR101354892B1 (ko) 안과용 방부 조성물
AU2013344497B2 (en) Aqueous liquid composition containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
JP2935339B2 (ja) 外用消毒液
CA2758858C (en) Aqueous ophthalmic compositions containing anionic therapeutic agents
AU2009288277B2 (en) Pharmaceutical composition having relatively low ionic strength
JP4892291B2 (ja) 眼科用防腐組成物
WO2012034659A2 (de) Pharmazeutische zusammensetzung, enthaltend elektrochemisch aktivierte salzlösung
JP2000229863A (ja) 咽頭疾患用組成物
JP2008174513A (ja) プロタミン及びホウ酸含有防腐剤

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired